title: [Oral administration of "Infectvac" for prevention of acute respiratory tract infections].
abstract: The efficacy of a newly developed polyvalent bacterial lysat vaccine "Infectvac" was tested in experimental studies in animals. It was shown that a local application (oral, aerogenic) prevent the animals from a lethal bacterial (S. pneumoniae) or viral (A/PR/8/34) infection. In first clinical trials a good compatibility of the drug was demonstrated.
authors: Abteilung Immunologie des Forschungsinstitutes für Lungenkrankheiten und Tuberkulose, Berlin-Buch/DDR.
authors: P
authors: P
authors: Luther
authors: I
authors: I
authors: Brachmann
authors: D
authors: D
authors: Werchan
authors: C
authors: C
authors: Wittig
authors: H
authors: H
authors: Tischner
mesh_terms: D000281:Administration, Intranasal; D000284:Administration, Oral; D000328:Adult; D000818:Animals; D001419:Bacteria / Q000276:immunology; D001424:Bacterial Infections / Q000276:immunology / Q000517:prevention & control*; D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012141:Respiratory Tract Infections / Q000276:immunology / Q000517:prevention & control*; D015164:Vaccines, Inactivated / Q000008:administration & dosage / Q000276:immunology
chemical_list: D001428:Bacterial Vaccines; D015164:Vaccines, Inactivated
vernacular_title: Orale Applikation von "Infectvac" zur Prophylaxe von akuten respiratorische Infektionen (ARI).